SEATTLE, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MAXAID, founded in 2016, is a major nonprofit in the Diseases & Disorders sector that reported $309.1M in total revenue in fiscal year 2024. Expenses of $371.0M exceeded revenue, resulting in a 20% operating deficit.
THE PRIMARY PURPOSE OF MAXAID IS TO CARRY OUT TREATMENT ACCESS SOLUTIONS FOR ONCOLOGY AND OTHER CRITICAL ILLNESS PRODUCTS IN LOW AND MIDDLE INCOME COUNTRIES IN SUPPORT OF THE MAX FOUNDATION'S MISSION.
MAXAID HOSTS THE MAX FOUNDATION'S COLLABORATION WITH LEADING GLOBAL HEALTHCARE MANUFACTURERS, FOR HUMANITARIAN ACCESS TO CRITICAL MEDICINES UNDER THE UMBRELLA OF MAX ACCESS SOLUTIONS. WITHIN THIS...
MAXAID HOSTS THE MAX FOUNDATION'S COLLABORATION WITH LEADING GLOBAL HEALTHCARE MANUFACTURERS, FOR HUMANITARIAN ACCESS TO CRITICAL MEDICINES UNDER THE UMBRELLA OF MAX ACCESS SOLUTIONS. WITHIN THIS PROGRAM, MEDICINES ARE PROCURED FROM DRUG MANUFACTURERS ANDCHANNELED TO INDIVIDUAL PATIENTS THROUGH THE MAX FOUNDATION'S NETWORK OF HEALTHCARE PROVIDERS AND TREATMENT CENTERS. THE COLLABORATIONS ENABLE THOUSANDS OF PATIENTS IN LOW- AND MIDDLE-INCOME COUNTRIES TO ACCESS MUCH NEEDED ONCOLOGY PRODUCTS THAT THEY WOULD NOT HAVE OTHERWISE BEEN ABLE TO ACCESS. ACCESS TO MEDICINES WAS ENABLED THROUGH THE MAX FOUNDATION'S PATIENT-CENTERED TREATMENT ACCESS MODEL CALLED MAX ACCESS SOLUTIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $309,119,754 | $311,110,506 | 0.0% |
| Expenses | $371,015,221 | $295,174,481 | +0.3% |
| Net Income | $-61,895,467 | $15,936,025 | -4.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PATRICIA GARCIA-GONZALEZ | CHIEF EXECUTIVE OFFICER | 5.00 |
Officer
Director
|
$0 | $26,903 | $349,289 |
| PAULA BOULTBEE | BOARD CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| CURT MALLOY | BOARD TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JERALD JERRY RADICH MD | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| SUSAN JERIAN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MABEL WOLOJ | BOARD SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| EDGAR THOMAS | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MARIA PIA RUFFILLI | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN MENAPACE | CFO & VP, ADMINISTRATION | 2.00 |
Officer
|
$0 | $18,740 | $228,059 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $309,119,754 | $371,015,221 | $73,562,738 | $-61,895,467 |
| 2023 | $311,110,506 | $295,174,481 | $136,816,838 | $15,936,025 |
| 2022 | $317,889,984 | $374,245,160 | $121,782,891 | $-56,355,176 |
| 2021 | $455,604,907 | $470,828,729 | $177,397,532 | $-15,223,822 |
| 2020 | $521,790,603 | $439,372,145 | $193,262,872 | $82,418,458 |
| 2019 | $185,050,573 | $256,924,291 | $110,472,066 | $-71,873,718 |
| 2018 | $295,408,696 | $253,356,148 | $182,220,385 | $42,052,548 |
Compare MAXAID with other nonprofits in Washington and across the country.